Aliskiren/hydrochlorothiazide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Aliskiren/hydrochlorothiazide, covering 2011-05-23 to 2012-09-20. Get the full timeline:
Most recent: EMA Withdrawn: Riprazo HCT (aliskiren;hydrochlorothiazide) — Novartis Europharm Ltd.